This is the authors' abstract. We don't add key points for this paper.
Aim To evaluate the drug release capacity and the antibacterial properties of incorporating chlorhexidine digluconate (CHX) liposomal formulation in a calcium hydroxide-based root canal sealer. Methods The sealers tested were SEALAPEX and APEXIT, containing 1 % of the different liposomal formulations. The drug release capacity was assessed by Rhodamine B detection and CHX detection by spectrophotometer, and the antibacterial properties by agar diffusion test (ADT), direct contact test (DCT), and modified direct contact test (MDCT). Results The best release profile was found for the SEALAPEX with the liposomal formulation using the 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)/L-α-phosphatidylcholine hydrogenated (HSPC). This liposomal formulation containing 4 % CHX improved the antibacterial properties of SEALAPEX compared to non-encapsulated CHX and control. Conclusion The liposomal formulation increased the release of CHX, improving the antibacterial effect of the SEALAPEX, representing a promising strategy for local anti-biofilm therapy in the endodontic field.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Raddi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: